Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imugene.
RELATED STOCKHEAD STORIES
Health & Biotech
Invion led a group of ASX cancer stocks up after promising news
News
Quadruple Shot: These 12 ASX stocks have outperformed Bitcoin by 15 times – gaining over 300pc in 2021
News
Hot Money Monday: Global Health leads the pack as biotech heat up
Experts
ScoPo’s Powerplays: Hearing tech, medical devices to ride out choppy market
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Imugene led a biotech buying frenzy on the ASX today
News
Market highlights and 5 ASX small caps to watch on Tuesday
News
Hot Money Monday: Red Hill runs hot, as iron ore markets run even hotter
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
Health & Biotech
Imugene shares up 6pc on after ‘milestone’ for cancer vaccine
News
Last Orders: Sixth straight day of gains for small caps
News
Weekly ASX Small Cap Wrap: Who’s passed the test this week?
Health & Biotech
Imugene gains 10pc on cancer vaccine progress; 3 other biotechs getting patents
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
Health & Biotech
Imugene, Immutep both complete recruitment for cancer treatment studies
Health & Biotech
First patient dosed with Imugene’s lung cancer drug candidate
Health & Biotech
